High capacity recombinant adenoviral vector for treatment of hemophilia A

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7238346
APP PUB NO 20040005293A1
SERIAL NO

10191760

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to adenoviral vectors. More particularly, this invention relates to recombinant high capacity adenoviral vectors which can be employed in the treatment of hemophilia A, as well as methods and process for their creation and use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZWRIJVISSCHESTRAAT 120 ZWIJNAARDE B-9052 BELGIUM
COLOGNE UNIVERSITY OFKERPENER STR 34 50931 COLOGNE
D COLLEN RESEARCH FOUNDATION VZWK U LEUVEN HERESTRAAT 49

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chuah, Marinee Korbeek-Lo, BE 18 92
Kochanek, Stefan Cologne, DE 12 231
Schiedner, Gudrun Cologne, DE 10 197
Vandendriessche, Thierry Korbeek-Lo, BE 27 102

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation